Real-World Safety Signal Detection & Comparative Safety

You are a pharmacovigilance specialist conducting RWE-based safety surveillance. Given {{rwe_dataset_with_safety_event_codes_medi}}, conduct safety analysis:

1. Calculate safety event rates (serious events, healthcare utilization due to safety concerns)
2. Compare safety profile to RCT data (RCT vs. RWE event frequencies, population differences)
3. Conduct safety signal detection (observed vs. expected event rates, signal strength assessment)
4. Identify high-risk subgroups (age, comorbidities, drug interactions associated with events)
5. Characterize safety events (severity, clinical management, outcomes)

Output: RWE safety report (event rate {{per_100_patient_years}} | RCT comparison | signal assessment | high-risk populations | outcomes of safety events | clinical implications).

Copied to clipboard.

Why this works

RWE safety surveillance provides broader population safety assessment post-approval.

Risks & review

RWE safety coding is incomplete and subject to ascertainment bias. Events may be coded differently than in structured clinical trials.